nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—CYP1B1—Estradiol—osteoporosis	0.439	1	CbGbCtD
Procarbazine—XDH—Purine catabolism—PNP—osteoporosis	0.027	0.2	CbGpPWpGaD
Procarbazine—XDH—Purine metabolism—PNP—osteoporosis	0.0104	0.0769	CbGpPWpGaD
Procarbazine—XDH—Purine metabolism—ATIC—osteoporosis	0.0104	0.0769	CbGpPWpGaD
Procarbazine—XDH—Purine catabolism—GPX1—osteoporosis	0.00764	0.0566	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—PNP—osteoporosis	0.00521	0.0386	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—ATIC—osteoporosis	0.00521	0.0386	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—PRDX3—osteoporosis	0.00518	0.0384	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—CYP27A1—osteoporosis	0.00491	0.0364	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—SOD2—osteoporosis	0.00333	0.0246	CbGpPWpGaD
Procarbazine—XDH—Oxidative Stress—GPX1—osteoporosis	0.00317	0.0235	CbGpPWpGaD
Procarbazine—XDH—Purine metabolism—GPX1—osteoporosis	0.00294	0.0218	CbGpPWpGaD
Procarbazine—CYP1B1—Estrogen Receptor Pathway—ESR1—osteoporosis	0.00272	0.0202	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—CYP19A1—osteoporosis	0.00258	0.0191	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00228	0.0169	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00225	0.0167	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00185	0.0137	CbGpPWpGaD
Procarbazine—CYP1B1—Endogenous sterols—POMC—osteoporosis	0.00155	0.0115	CbGpPWpGaD
Procarbazine—CYP1B1—Tryptophan metabolism—CYP19A1—osteoporosis	0.00148	0.011	CbGpPWpGaD
Procarbazine—XDH—Nucleotide metabolism—GPX1—osteoporosis	0.00148	0.0109	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—SOD2—osteoporosis	0.00141	0.0104	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—GPX1—osteoporosis	0.00134	0.00994	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00124	0.00917	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.0012	0.00888	CbGpPWpGaD
Procarbazine—CYP1B1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00118	0.00877	CbGpPWpGaD
Procarbazine—CYP1B1—Arachidonic acid metabolism—GPX1—osteoporosis	0.00113	0.00837	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.00099	0.00734	CbGpPWpGaD
Procarbazine—CYP1B1—Biological oxidations—CYP27A1—osteoporosis	0.000983	0.00728	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000972	0.0072	CbGpPWpGaD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000969	0.00718	CbGpPWpGaD
Procarbazine—XDH—Selenium Micronutrient Network—IL1B—osteoporosis	0.000735	0.00544	CbGpPWpGaD
Procarbazine—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00072	0.00534	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000661	0.0049	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000657	0.00487	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000623	0.00462	CbGpPWpGaD
Procarbazine—CYP1B1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000584	0.00433	CbGpPWpGaD
Procarbazine—Abdominal pain—Raloxifene—osteoporosis	0.000583	0.00137	CcSEcCtD
Procarbazine—Body temperature increased—Raloxifene—osteoporosis	0.000583	0.00137	CcSEcCtD
Procarbazine—Urticaria—Ibandronate—osteoporosis	0.00058	0.00136	CcSEcCtD
Procarbazine—Abdominal pain—Ibandronate—osteoporosis	0.000577	0.00135	CcSEcCtD
Procarbazine—Body temperature increased—Ibandronate—osteoporosis	0.000577	0.00135	CcSEcCtD
Procarbazine—Confusional state—Pamidronate—osteoporosis	0.000577	0.00135	CcSEcCtD
Procarbazine—Syncope—Zoledronate—osteoporosis	0.000574	0.00135	CcSEcCtD
Procarbazine—Leukopenia—Zoledronate—osteoporosis	0.000573	0.00134	CcSEcCtD
Procarbazine—Oedema—Pamidronate—osteoporosis	0.000572	0.00134	CcSEcCtD
Procarbazine—Haemoglobin—Estradiol—osteoporosis	0.000569	0.00134	CcSEcCtD
Procarbazine—Infection—Pamidronate—osteoporosis	0.000568	0.00133	CcSEcCtD
Procarbazine—Urticaria—Calcitriol—osteoporosis	0.000568	0.00133	CcSEcCtD
Procarbazine—Haemorrhage—Estradiol—osteoporosis	0.000567	0.00133	CcSEcCtD
Procarbazine—Abdominal pain—Calcitriol—osteoporosis	0.000565	0.00133	CcSEcCtD
Procarbazine—Body temperature increased—Calcitriol—osteoporosis	0.000565	0.00133	CcSEcCtD
Procarbazine—Shock—Pamidronate—osteoporosis	0.000563	0.00132	CcSEcCtD
Procarbazine—Loss of consciousness—Zoledronate—osteoporosis	0.000563	0.00132	CcSEcCtD
Procarbazine—Hypersensitivity—Estropipate—osteoporosis	0.000561	0.00132	CcSEcCtD
Procarbazine—Thrombocytopenia—Pamidronate—osteoporosis	0.00056	0.00131	CcSEcCtD
Procarbazine—Vomiting—Etidronic acid—osteoporosis	0.000559	0.00131	CcSEcCtD
Procarbazine—Cough—Zoledronate—osteoporosis	0.000558	0.00131	CcSEcCtD
Procarbazine—Tachycardia—Pamidronate—osteoporosis	0.000558	0.00131	CcSEcCtD
Procarbazine—Rash—Etidronic acid—osteoporosis	0.000555	0.0013	CcSEcCtD
Procarbazine—Convulsion—Zoledronate—osteoporosis	0.000555	0.0013	CcSEcCtD
Procarbazine—Dermatitis—Etidronic acid—osteoporosis	0.000554	0.0013	CcSEcCtD
Procarbazine—Hyperhidrosis—Pamidronate—osteoporosis	0.000553	0.0013	CcSEcCtD
Procarbazine—Syncope—Conjugated Estrogens—osteoporosis	0.000553	0.0013	CcSEcCtD
Procarbazine—Hypertension—Zoledronate—osteoporosis	0.000553	0.0013	CcSEcCtD
Procarbazine—Hypersensitivity—Alendronate—osteoporosis	0.000552	0.0013	CcSEcCtD
Procarbazine—Headache—Etidronic acid—osteoporosis	0.000551	0.00129	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000548	0.00129	CcSEcCtD
Procarbazine—XDH—Metabolism—FDPS—osteoporosis	0.000546	0.00405	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PKM—osteoporosis	0.000546	0.00405	CbGpPWpGaD
Procarbazine—Asthenia—Estropipate—osteoporosis	0.000546	0.00128	CcSEcCtD
Procarbazine—Anorexia—Pamidronate—osteoporosis	0.000545	0.00128	CcSEcCtD
Procarbazine—Arthralgia—Zoledronate—osteoporosis	0.000545	0.00128	CcSEcCtD
Procarbazine—Myalgia—Zoledronate—osteoporosis	0.000545	0.00128	CcSEcCtD
Procarbazine—Insomnia—Risedronate—osteoporosis	0.000544	0.00128	CcSEcCtD
Procarbazine—Anxiety—Zoledronate—osteoporosis	0.000543	0.00127	CcSEcCtD
Procarbazine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000542	0.00127	CcSEcCtD
Procarbazine—Paraesthesia—Risedronate—osteoporosis	0.00054	0.00127	CcSEcCtD
Procarbazine—Pruritus—Estropipate—osteoporosis	0.000539	0.00126	CcSEcCtD
Procarbazine—Asthenia—Alendronate—osteoporosis	0.000538	0.00126	CcSEcCtD
Procarbazine—Hypersensitivity—Ibandronate—osteoporosis	0.000538	0.00126	CcSEcCtD
Procarbazine—Cough—Conjugated Estrogens—osteoporosis	0.000538	0.00126	CcSEcCtD
Procarbazine—Hypotension—Pamidronate—osteoporosis	0.000534	0.00125	CcSEcCtD
Procarbazine—Convulsion—Conjugated Estrogens—osteoporosis	0.000534	0.00125	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—TNF—osteoporosis	0.000533	0.00395	CbGpPWpGaD
Procarbazine—Dry mouth—Zoledronate—osteoporosis	0.000533	0.00125	CcSEcCtD
Procarbazine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000532	0.00125	CcSEcCtD
Procarbazine—Pruritus—Alendronate—osteoporosis	0.00053	0.00124	CcSEcCtD
Procarbazine—Constipation—Ethinyl Estradiol—osteoporosis	0.000528	0.00124	CcSEcCtD
Procarbazine—Confusional state—Zoledronate—osteoporosis	0.000527	0.00124	CcSEcCtD
Procarbazine—Hypersensitivity—Calcitriol—osteoporosis	0.000526	0.00123	CcSEcCtD
Procarbazine—Flushing—Estradiol—osteoporosis	0.000526	0.00123	CcSEcCtD
Procarbazine—Myalgia—Conjugated Estrogens—osteoporosis	0.000525	0.00123	CcSEcCtD
Procarbazine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000525	0.00123	CcSEcCtD
Procarbazine—Asthenia—Ibandronate—osteoporosis	0.000524	0.00123	CcSEcCtD
Procarbazine—Anxiety—Conjugated Estrogens—osteoporosis	0.000523	0.00123	CcSEcCtD
Procarbazine—Nausea—Etidronic acid—osteoporosis	0.000523	0.00123	CcSEcCtD
Procarbazine—Oedema—Zoledronate—osteoporosis	0.000522	0.00123	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000521	0.00122	CcSEcCtD
Procarbazine—Diarrhoea—Estropipate—osteoporosis	0.000521	0.00122	CcSEcCtD
Procarbazine—Infection—Zoledronate—osteoporosis	0.000519	0.00122	CcSEcCtD
Procarbazine—Fatigue—Risedronate—osteoporosis	0.000519	0.00122	CcSEcCtD
Procarbazine—XDH—Metabolism—GPD2—osteoporosis	0.000518	0.00384	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PGLS—osteoporosis	0.000518	0.00384	CbGpPWpGaD
Procarbazine—Insomnia—Pamidronate—osteoporosis	0.000517	0.00121	CcSEcCtD
Procarbazine—Pruritus—Ibandronate—osteoporosis	0.000516	0.00121	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—CYP19A1—osteoporosis	0.000516	0.00383	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000515	0.00382	CbGpPWpGaD
Procarbazine—Pain—Risedronate—osteoporosis	0.000514	0.00121	CcSEcCtD
Procarbazine—Constipation—Risedronate—osteoporosis	0.000514	0.00121	CcSEcCtD
Procarbazine—Shock—Zoledronate—osteoporosis	0.000514	0.00121	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.000514	0.00381	CbGpPWpGaD
Procarbazine—Paraesthesia—Pamidronate—osteoporosis	0.000513	0.0012	CcSEcCtD
Procarbazine—Diarrhoea—Alendronate—osteoporosis	0.000513	0.0012	CcSEcCtD
Procarbazine—Asthenia—Calcitriol—osteoporosis	0.000513	0.0012	CcSEcCtD
Procarbazine—Thrombocytopenia—Zoledronate—osteoporosis	0.000511	0.0012	CcSEcCtD
Procarbazine—Tachycardia—Zoledronate—osteoporosis	0.00051	0.0012	CcSEcCtD
Procarbazine—CYP1B1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000509	0.00377	CbGpPWpGaD
Procarbazine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000508	0.00119	CcSEcCtD
Procarbazine—Chills—Estradiol—osteoporosis	0.000508	0.00119	CcSEcCtD
Procarbazine—Somnolence—Pamidronate—osteoporosis	0.000508	0.00119	CcSEcCtD
Procarbazine—Pruritus—Calcitriol—osteoporosis	0.000506	0.00119	CcSEcCtD
Procarbazine—Hyperhidrosis—Zoledronate—osteoporosis	0.000505	0.00118	CcSEcCtD
Procarbazine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000505	0.00118	CcSEcCtD
Procarbazine—Diarrhoea—Raloxifene—osteoporosis	0.000504	0.00118	CcSEcCtD
Procarbazine—Dizziness—Estropipate—osteoporosis	0.000503	0.00118	CcSEcCtD
Procarbazine—Oedema—Conjugated Estrogens—osteoporosis	0.000503	0.00118	CcSEcCtD
Procarbazine—Alopecia—Estradiol—osteoporosis	0.000501	0.00117	CcSEcCtD
Procarbazine—Infection—Conjugated Estrogens—osteoporosis	0.0005	0.00117	CcSEcCtD
Procarbazine—Diarrhoea—Ibandronate—osteoporosis	0.000499	0.00117	CcSEcCtD
Procarbazine—Anorexia—Zoledronate—osteoporosis	0.000498	0.00117	CcSEcCtD
Procarbazine—Decreased appetite—Pamidronate—osteoporosis	0.000497	0.00117	CcSEcCtD
Procarbazine—Dizziness—Alendronate—osteoporosis	0.000496	0.00116	CcSEcCtD
Procarbazine—Shock—Conjugated Estrogens—osteoporosis	0.000495	0.00116	CcSEcCtD
Procarbazine—Fatigue—Pamidronate—osteoporosis	0.000493	0.00116	CcSEcCtD
Procarbazine—Gastrointestinal pain—Risedronate—osteoporosis	0.000492	0.00115	CcSEcCtD
Procarbazine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000491	0.00115	CcSEcCtD
Procarbazine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00049	0.00115	CcSEcCtD
Procarbazine—Constipation—Pamidronate—osteoporosis	0.000489	0.00115	CcSEcCtD
Procarbazine—Pain—Pamidronate—osteoporosis	0.000489	0.00115	CcSEcCtD
Procarbazine—Diarrhoea—Calcitriol—osteoporosis	0.000489	0.00115	CcSEcCtD
Procarbazine—Hypotension—Zoledronate—osteoporosis	0.000488	0.00114	CcSEcCtD
Procarbazine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000488	0.00114	CcSEcCtD
Procarbazine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000488	0.00114	CcSEcCtD
Procarbazine—Dizziness—Raloxifene—osteoporosis	0.000488	0.00114	CcSEcCtD
Procarbazine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000486	0.00114	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000484	0.00359	CbGpPWpGaD
Procarbazine—Tension—Estradiol—osteoporosis	0.000484	0.00114	CcSEcCtD
Procarbazine—Vomiting—Estropipate—osteoporosis	0.000484	0.00114	CcSEcCtD
Procarbazine—Dizziness—Ibandronate—osteoporosis	0.000483	0.00113	CcSEcCtD
Procarbazine—Rash—Estropipate—osteoporosis	0.00048	0.00113	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.00048	0.00356	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.00048	0.00356	CbGpPWpGaD
Procarbazine—Dermatitis—Estropipate—osteoporosis	0.000479	0.00112	CcSEcCtD
Procarbazine—Anorexia—Conjugated Estrogens—osteoporosis	0.000479	0.00112	CcSEcCtD
Procarbazine—Nervousness—Estradiol—osteoporosis	0.000479	0.00112	CcSEcCtD
Procarbazine—Urticaria—Risedronate—osteoporosis	0.000478	0.00112	CcSEcCtD
Procarbazine—Headache—Estropipate—osteoporosis	0.000477	0.00112	CcSEcCtD
Procarbazine—Vomiting—Alendronate—osteoporosis	0.000477	0.00112	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000476	0.00112	CcSEcCtD
Procarbazine—Abdominal pain—Risedronate—osteoporosis	0.000476	0.00112	CcSEcCtD
Procarbazine—Body temperature increased—Risedronate—osteoporosis	0.000476	0.00112	CcSEcCtD
Procarbazine—XDH—Metabolism—ATIC—osteoporosis	0.000474	0.00351	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PNP—osteoporosis	0.000474	0.00351	CbGpPWpGaD
Procarbazine—Rash—Alendronate—osteoporosis	0.000473	0.00111	CcSEcCtD
Procarbazine—Insomnia—Zoledronate—osteoporosis	0.000472	0.00111	CcSEcCtD
Procarbazine—Dermatitis—Alendronate—osteoporosis	0.000472	0.00111	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000472	0.0035	CbGpPWpGaD
Procarbazine—Feeling abnormal—Pamidronate—osteoporosis	0.000471	0.00111	CcSEcCtD
Procarbazine—Hypotension—Conjugated Estrogens—osteoporosis	0.00047	0.0011	CcSEcCtD
Procarbazine—Headache—Alendronate—osteoporosis	0.00047	0.0011	CcSEcCtD
Procarbazine—Paraesthesia—Zoledronate—osteoporosis	0.000469	0.0011	CcSEcCtD
Procarbazine—Vomiting—Raloxifene—osteoporosis	0.000469	0.0011	CcSEcCtD
Procarbazine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000468	0.0011	CcSEcCtD
Procarbazine—Rash—Raloxifene—osteoporosis	0.000465	0.00109	CcSEcCtD
Procarbazine—Dermatitis—Raloxifene—osteoporosis	0.000464	0.00109	CcSEcCtD
Procarbazine—Somnolence—Zoledronate—osteoporosis	0.000464	0.00109	CcSEcCtD
Procarbazine—Vomiting—Ibandronate—osteoporosis	0.000464	0.00109	CcSEcCtD
Procarbazine—Tremor—Estradiol—osteoporosis	0.000462	0.00108	CcSEcCtD
Procarbazine—Headache—Raloxifene—osteoporosis	0.000462	0.00108	CcSEcCtD
Procarbazine—Rash—Ibandronate—osteoporosis	0.00046	0.00108	CcSEcCtD
Procarbazine—Dermatitis—Ibandronate—osteoporosis	0.00046	0.00108	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000458	0.00107	CcSEcCtD
Procarbazine—Headache—Ibandronate—osteoporosis	0.000457	0.00107	CcSEcCtD
Procarbazine—Insomnia—Conjugated Estrogens—osteoporosis	0.000455	0.00107	CcSEcCtD
Procarbazine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000455	0.00107	CcSEcCtD
Procarbazine—Vomiting—Calcitriol—osteoporosis	0.000454	0.00107	CcSEcCtD
Procarbazine—Decreased appetite—Zoledronate—osteoporosis	0.000454	0.00107	CcSEcCtD
Procarbazine—Nausea—Estropipate—osteoporosis	0.000452	0.00106	CcSEcCtD
Procarbazine—Abdominal pain—Pamidronate—osteoporosis	0.000452	0.00106	CcSEcCtD
Procarbazine—Body temperature increased—Pamidronate—osteoporosis	0.000452	0.00106	CcSEcCtD
Procarbazine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000452	0.00106	CcSEcCtD
Procarbazine—Rash—Calcitriol—osteoporosis	0.000451	0.00106	CcSEcCtD
Procarbazine—Fatigue—Zoledronate—osteoporosis	0.00045	0.00106	CcSEcCtD
Procarbazine—Dermatitis—Calcitriol—osteoporosis	0.00045	0.00106	CcSEcCtD
Procarbazine—Headache—Calcitriol—osteoporosis	0.000448	0.00105	CcSEcCtD
Procarbazine—Somnolence—Conjugated Estrogens—osteoporosis	0.000447	0.00105	CcSEcCtD
Procarbazine—Constipation—Zoledronate—osteoporosis	0.000447	0.00105	CcSEcCtD
Procarbazine—Pain—Zoledronate—osteoporosis	0.000447	0.00105	CcSEcCtD
Procarbazine—Nausea—Alendronate—osteoporosis	0.000445	0.00104	CcSEcCtD
Procarbazine—Hypersensitivity—Risedronate—osteoporosis	0.000443	0.00104	CcSEcCtD
Procarbazine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000443	0.00104	CcSEcCtD
Procarbazine—Syncope—Estradiol—osteoporosis	0.000442	0.00104	CcSEcCtD
Procarbazine—Nausea—Raloxifene—osteoporosis	0.000438	0.00103	CcSEcCtD
Procarbazine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000437	0.00103	CcSEcCtD
Procarbazine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000437	0.00102	CcSEcCtD
Procarbazine—Fatigue—Conjugated Estrogens—osteoporosis	0.000434	0.00102	CcSEcCtD
Procarbazine—Nausea—Ibandronate—osteoporosis	0.000434	0.00102	CcSEcCtD
Procarbazine—Loss of consciousness—Estradiol—osteoporosis	0.000434	0.00102	CcSEcCtD
Procarbazine—Asthenia—Risedronate—osteoporosis	0.000432	0.00101	CcSEcCtD
Procarbazine—Feeling abnormal—Zoledronate—osteoporosis	0.00043	0.00101	CcSEcCtD
Procarbazine—Cough—Estradiol—osteoporosis	0.00043	0.00101	CcSEcCtD
Procarbazine—XDH—Selenium Micronutrient Network—IL6—osteoporosis	0.00043	0.00319	CbGpPWpGaD
Procarbazine—Pain—Conjugated Estrogens—osteoporosis	0.00043	0.00101	CcSEcCtD
Procarbazine—Constipation—Conjugated Estrogens—osteoporosis	0.00043	0.00101	CcSEcCtD
Procarbazine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000427	0.001	CcSEcCtD
Procarbazine—Hypertension—Estradiol—osteoporosis	0.000426	0.000999	CcSEcCtD
Procarbazine—Pruritus—Risedronate—osteoporosis	0.000426	0.000998	CcSEcCtD
Procarbazine—Nausea—Calcitriol—osteoporosis	0.000424	0.000996	CcSEcCtD
Procarbazine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000422	0.00099	CcSEcCtD
Procarbazine—Hypersensitivity—Pamidronate—osteoporosis	0.000421	0.000988	CcSEcCtD
Procarbazine—Arthralgia—Estradiol—osteoporosis	0.00042	0.000985	CcSEcCtD
Procarbazine—Myalgia—Estradiol—osteoporosis	0.00042	0.000985	CcSEcCtD
Procarbazine—Anxiety—Estradiol—osteoporosis	0.000418	0.000982	CcSEcCtD
Procarbazine—Urticaria—Zoledronate—osteoporosis	0.000415	0.000973	CcSEcCtD
Procarbazine—Body temperature increased—Zoledronate—osteoporosis	0.000413	0.000969	CcSEcCtD
Procarbazine—Abdominal pain—Zoledronate—osteoporosis	0.000413	0.000969	CcSEcCtD
Procarbazine—Diarrhoea—Risedronate—osteoporosis	0.000412	0.000966	CcSEcCtD
Procarbazine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000411	0.000965	CcSEcCtD
Procarbazine—Dry mouth—Estradiol—osteoporosis	0.000411	0.000963	CcSEcCtD
Procarbazine—Asthenia—Pamidronate—osteoporosis	0.00041	0.000962	CcSEcCtD
Procarbazine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000408	0.000957	CcSEcCtD
Procarbazine—Confusional state—Estradiol—osteoporosis	0.000406	0.000952	CcSEcCtD
Procarbazine—Pruritus—Pamidronate—osteoporosis	0.000405	0.000949	CcSEcCtD
Procarbazine—XDH—Metabolism—OXCT1—osteoporosis	0.000403	0.00298	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CA2—osteoporosis	0.000403	0.00298	CbGpPWpGaD
Procarbazine—Oedema—Estradiol—osteoporosis	0.000403	0.000944	CcSEcCtD
Procarbazine—Infection—Estradiol—osteoporosis	0.0004	0.000938	CcSEcCtD
Procarbazine—Urticaria—Conjugated Estrogens—osteoporosis	0.0004	0.000937	CcSEcCtD
Procarbazine—Dizziness—Risedronate—osteoporosis	0.000398	0.000933	CcSEcCtD
Procarbazine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000398	0.000933	CcSEcCtD
Procarbazine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000398	0.000933	CcSEcCtD
Procarbazine—Shock—Estradiol—osteoporosis	0.000396	0.000929	CcSEcCtD
Procarbazine—Tachycardia—Estradiol—osteoporosis	0.000393	0.000922	CcSEcCtD
Procarbazine—XDH—Metabolism—MGLL—osteoporosis	0.000392	0.00291	CbGpPWpGaD
Procarbazine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000392	0.00092	CcSEcCtD
Procarbazine—Diarrhoea—Pamidronate—osteoporosis	0.000391	0.000918	CcSEcCtD
Procarbazine—Hyperhidrosis—Estradiol—osteoporosis	0.000389	0.000913	CcSEcCtD
Procarbazine—Rash—Ethinyl Estradiol—osteoporosis	0.000389	0.000913	CcSEcCtD
Procarbazine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000389	0.000912	CcSEcCtD
Procarbazine—Headache—Ethinyl Estradiol—osteoporosis	0.000387	0.000907	CcSEcCtD
Procarbazine—Hypersensitivity—Zoledronate—osteoporosis	0.000385	0.000903	CcSEcCtD
Procarbazine—Vomiting—Risedronate—osteoporosis	0.000382	0.000897	CcSEcCtD
Procarbazine—Rash—Risedronate—osteoporosis	0.000379	0.00089	CcSEcCtD
Procarbazine—Dermatitis—Risedronate—osteoporosis	0.000379	0.000889	CcSEcCtD
Procarbazine—Dizziness—Pamidronate—osteoporosis	0.000378	0.000887	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000377	0.0028	CbGpPWpGaD
Procarbazine—Headache—Risedronate—osteoporosis	0.000377	0.000884	CcSEcCtD
Procarbazine—Asthenia—Zoledronate—osteoporosis	0.000375	0.000879	CcSEcCtD
Procarbazine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000371	0.000869	CcSEcCtD
Procarbazine—Pruritus—Zoledronate—osteoporosis	0.00037	0.000867	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000367	0.00086	CcSEcCtD
Procarbazine—Nausea—Ethinyl Estradiol—osteoporosis	0.000366	0.00086	CcSEcCtD
Procarbazine—Insomnia—Estradiol—osteoporosis	0.000364	0.000854	CcSEcCtD
Procarbazine—Vomiting—Pamidronate—osteoporosis	0.000364	0.000853	CcSEcCtD
Procarbazine—Paraesthesia—Estradiol—osteoporosis	0.000361	0.000848	CcSEcCtD
Procarbazine—Asthenia—Conjugated Estrogens—osteoporosis	0.000361	0.000847	CcSEcCtD
Procarbazine—Rash—Pamidronate—osteoporosis	0.000361	0.000846	CcSEcCtD
Procarbazine—Dermatitis—Pamidronate—osteoporosis	0.00036	0.000845	CcSEcCtD
Procarbazine—Headache—Pamidronate—osteoporosis	0.000358	0.00084	CcSEcCtD
Procarbazine—Somnolence—Estradiol—osteoporosis	0.000358	0.000839	CcSEcCtD
Procarbazine—Diarrhoea—Zoledronate—osteoporosis	0.000357	0.000838	CcSEcCtD
Procarbazine—Nausea—Risedronate—osteoporosis	0.000357	0.000838	CcSEcCtD
Procarbazine—Pruritus—Conjugated Estrogens—osteoporosis	0.000356	0.000835	CcSEcCtD
Procarbazine—Decreased appetite—Estradiol—osteoporosis	0.00035	0.000821	CcSEcCtD
Procarbazine—Fatigue—Estradiol—osteoporosis	0.000347	0.000814	CcSEcCtD
Procarbazine—Dizziness—Zoledronate—osteoporosis	0.000345	0.00081	CcSEcCtD
Procarbazine—Pain—Estradiol—osteoporosis	0.000344	0.000808	CcSEcCtD
Procarbazine—Constipation—Estradiol—osteoporosis	0.000344	0.000808	CcSEcCtD
Procarbazine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000344	0.000807	CcSEcCtD
Procarbazine—Nausea—Pamidronate—osteoporosis	0.00034	0.000797	CcSEcCtD
Procarbazine—XDH—Metabolism—IDH2—osteoporosis	0.000334	0.00247	CbGpPWpGaD
Procarbazine—Dizziness—Conjugated Estrogens—osteoporosis	0.000333	0.00078	CcSEcCtD
Procarbazine—Vomiting—Zoledronate—osteoporosis	0.000332	0.000779	CcSEcCtD
Procarbazine—Feeling abnormal—Estradiol—osteoporosis	0.000332	0.000778	CcSEcCtD
Procarbazine—Rash—Zoledronate—osteoporosis	0.000329	0.000773	CcSEcCtD
Procarbazine—Gastrointestinal pain—Estradiol—osteoporosis	0.000329	0.000772	CcSEcCtD
Procarbazine—Dermatitis—Zoledronate—osteoporosis	0.000329	0.000772	CcSEcCtD
Procarbazine—Headache—Zoledronate—osteoporosis	0.000327	0.000768	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000321	0.00238	CbGpPWpGaD
Procarbazine—Vomiting—Conjugated Estrogens—osteoporosis	0.00032	0.00075	CcSEcCtD
Procarbazine—Urticaria—Estradiol—osteoporosis	0.00032	0.00075	CcSEcCtD
Procarbazine—Body temperature increased—Estradiol—osteoporosis	0.000318	0.000746	CcSEcCtD
Procarbazine—Abdominal pain—Estradiol—osteoporosis	0.000318	0.000746	CcSEcCtD
Procarbazine—Rash—Conjugated Estrogens—osteoporosis	0.000317	0.000744	CcSEcCtD
Procarbazine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000317	0.000743	CcSEcCtD
Procarbazine—Headache—Conjugated Estrogens—osteoporosis	0.000315	0.000739	CcSEcCtD
Procarbazine—XDH—Metabolism—CYP27A1—osteoporosis	0.000314	0.00233	CbGpPWpGaD
Procarbazine—Nausea—Zoledronate—osteoporosis	0.00031	0.000728	CcSEcCtD
Procarbazine—CYP1B1—Biological oxidations—POMC—osteoporosis	0.00031	0.0023	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ACP5—osteoporosis	0.000305	0.00226	CbGpPWpGaD
Procarbazine—Nausea—Conjugated Estrogens—osteoporosis	0.000299	0.000701	CcSEcCtD
Procarbazine—Hypersensitivity—Estradiol—osteoporosis	0.000297	0.000696	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—PKM—osteoporosis	0.000293	0.00217	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—FDPS—osteoporosis	0.000293	0.00217	CbGpPWpGaD
Procarbazine—Asthenia—Estradiol—osteoporosis	0.000289	0.000678	CcSEcCtD
Procarbazine—Pruritus—Estradiol—osteoporosis	0.000285	0.000668	CcSEcCtD
Procarbazine—XDH—Metabolism—TPI1—osteoporosis	0.000284	0.0021	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GPD2—osteoporosis	0.000277	0.00206	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PGLS—osteoporosis	0.000277	0.00206	CbGpPWpGaD
Procarbazine—Diarrhoea—Estradiol—osteoporosis	0.000275	0.000646	CcSEcCtD
Procarbazine—XDH—Metabolism—P4HB—osteoporosis	0.000267	0.00198	CbGpPWpGaD
Procarbazine—Dizziness—Estradiol—osteoporosis	0.000266	0.000624	CcSEcCtD
Procarbazine—XDH—Metabolism—GAPDH—osteoporosis	0.000262	0.00194	CbGpPWpGaD
Procarbazine—Vomiting—Estradiol—osteoporosis	0.000256	0.0006	CcSEcCtD
Procarbazine—XDH—Metabolism—RAP1A—osteoporosis	0.000255	0.00189	CbGpPWpGaD
Procarbazine—Rash—Estradiol—osteoporosis	0.000254	0.000595	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—ATIC—osteoporosis	0.000254	0.00188	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PNP—osteoporosis	0.000254	0.00188	CbGpPWpGaD
Procarbazine—Dermatitis—Estradiol—osteoporosis	0.000254	0.000595	CcSEcCtD
Procarbazine—Headache—Estradiol—osteoporosis	0.000252	0.000592	CcSEcCtD
Procarbazine—Nausea—Estradiol—osteoporosis	0.000239	0.000561	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—OXCT1—osteoporosis	0.000216	0.0016	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CA2—osteoporosis	0.000216	0.0016	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—MGLL—osteoporosis	0.00021	0.00156	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ENO1—osteoporosis	0.000206	0.00153	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PSMA2—osteoporosis	0.000203	0.00151	CbGpPWpGaD
Procarbazine—XDH—Metabolism—PSMA5—osteoporosis	0.000203	0.00151	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000198	0.00147	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—IDH2—osteoporosis	0.000179	0.00132	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP27A1—osteoporosis	0.000168	0.00125	CbGpPWpGaD
Procarbazine—XDH—Metabolism—CYP19A1—osteoporosis	0.000165	0.00122	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ACP5—osteoporosis	0.000163	0.00121	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000161	0.0012	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—TPI1—osteoporosis	0.000152	0.00113	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—P4HB—osteoporosis	0.000143	0.00106	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GAPDH—osteoporosis	0.00014	0.00104	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—RAP1A—osteoporosis	0.000137	0.00101	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ADCY5—osteoporosis	0.000135	0.000998	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GPX1—osteoporosis	0.000134	0.000995	CbGpPWpGaD
Procarbazine—XDH—Metabolism—MTHFR—osteoporosis	0.000124	0.000918	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000119	0.000883	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ENO1—osteoporosis	0.00011	0.000818	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PSMA2—osteoporosis	0.000109	0.000806	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—PSMA5—osteoporosis	0.000109	0.000806	CbGpPWpGaD
Procarbazine—XDH—Metabolism—POMC—osteoporosis	9.9e-05	0.000734	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—CYP19A1—osteoporosis	8.83e-05	0.000654	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ADCY5—osteoporosis	7.21e-05	0.000535	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GPX1—osteoporosis	7.19e-05	0.000533	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—MTHFR—osteoporosis	6.63e-05	0.000492	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—POMC—osteoporosis	5.31e-05	0.000393	CbGpPWpGaD
